News

Wallstreetcn
2023.02.27 03:18
辉瑞就以超过 300 亿美元收购生物医药公司 Seagen 进行初步谈判，谈判尚处于早期阶段，不一定会达成协议。（华尔街日报）
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.